2008
DOI: 10.1016/s0065-230x(07)99004-1
|View full text |Cite
|
Sign up to set email alerts
|

The c‐myc Promoter: Still MysterY and Challenge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
216
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 186 publications
(224 citation statements)
references
References 1,147 publications
7
216
0
1
Order By: Relevance
“…Deregulation of c-myc expression is tumorigenic, promoting genomic instability (Chung and Levens, 2005;Wierstra and Alves, 2008), and thus a tight control is essential in cells. FBPs regulate c-myc transcription through the general transcription factor, TFIIH (Wierstra and Alves, 2008). In this study, we examine the possibility that FBP-1 is a valid caspase substrate.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Deregulation of c-myc expression is tumorigenic, promoting genomic instability (Chung and Levens, 2005;Wierstra and Alves, 2008), and thus a tight control is essential in cells. FBPs regulate c-myc transcription through the general transcription factor, TFIIH (Wierstra and Alves, 2008). In this study, we examine the possibility that FBP-1 is a valid caspase substrate.…”
Section: Discussionmentioning
confidence: 99%
“…However, even slight fluctuations in these amounts have dramatic consequences on cell fate. Therefore, c-myc evidently requires tight control and represents a promising target of anticancer therapy (Liu et al, 2007;Wierstra and Alves, 2008).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Baicalin (chemical structural formula: C21H18O11) is an active ingredient extracted from Scutellaria (Labiatae). Many studies have shown that baicalin can play an anti-tumor role through various means (Hoffman and Liebermann, 2008;Wierstra and Alves, 2008;Zhang et al, 2009). For example, the promotional effect of prostaglandin synthetase on tumor cells can be blocked by reducing cyclooxygenase-2 expression to inhibit prostaglandin E2 production.…”
Section: Introductionmentioning
confidence: 99%
“…In fact, deregulated c-myc gene expression due to shifting to an alternative first exon/promoter that harbors less efficient transcription elongation block may be related to the oncogenesis of Burkitt lymphoma (44). Overproduction of aromatase, a key enzyme in estrogen biosynthesis, occurs in the surrounding tissues of breast tumors due to transcriptional activation caused by switching from a weak physiological promoter to a strong promoter (45).…”
Section: Discussionmentioning
confidence: 99%